Value of Risk Stratification to Increase the Predictive Validity of HbA1c in Screening for Undiagnosed Diabetes in the US Population
- 10 June 2008
- journal article
- research article
- Published by Springer Science and Business Media LLC in Journal of General Internal Medicine
- Vol. 23 (9), 1346-1353
- https://doi.org/10.1007/s11606-008-0661-6
Abstract
No abstract availableKeywords
This publication has 41 references indexed in Scilit:
- Utility of A1C for Diabetes Screening in the 1999–2004 NHANES PopulationDiabetes Care, 2007
- Standards of Medical Care in Diabetes—2007Diabetes Care, 2007
- Relationship between HbA1c and indices of glucose tolerance derived from a standardized meal test in newly diagnosed treatment naive subjects with Type 2 diabetesDiabetic Medicine, 2006
- HbA1c screening for undiagnosed diabetes in New ZealandDiabetes/Metabolism Research and Reviews, 2004
- Executive Summary of the Third Report of the National Cholesterol Education Program (NCEP) Expert Panel on Detection, Evaluation, and Treatment of High Blood Cholesterol in Adults (Adult Treatment Panel III)JAMA, 2001
- Glycosylated Hemoglobin as a Diagnostic Test for Type 2 Diabetes MellitusJAMA, 2000
- The Cost-effectiveness of Screening for Type 2 DiabetesJAMA, 1998
- A clinical approach for the diagnosis of diabetes mellitus: an analysis using glycosylated hemoglobin levels. Meta-analysis Research Group on the Diagnosis of Diabetes Using Glycated Hemoglobin LevelsJAMA, 1996
- Onset of NIDDM occurs at Least 4–7 yr Before Clinical DiagnosisDiabetes Care, 1992
- The area above the ordinal dominance graph and the area below the receiver operating characteristic graphJournal of Mathematical Psychology, 1975